[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
News& Events::
Contact us::
Site Facilities::
Ethics & Permissions::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 13, Issue 4 (Winter 2016) ::
Sci J Iran Blood Transfus Organ 2016, 13(4): 277-283 Back to browse issues page
The results of two methods of factor VIII:C in patients with hemophilia A
F. Vossough Shirayeh , M. Ahmadinejad , Gh. Toogeh , K. Karimi , M.R. Tabatabaei
Keywords: Key words: Hemophilia A, Factor VIII, Prevalence
Full-Text [PDF 233 kb]   (3972 Downloads)     |   Abstract (HTML)  (4681 Views)
Type of Study: Research | Subject: Hematology
Published: 2016/12/24
Full-Text:   (11200 Views)
References:
 
  1. Franchini M, Favaloro EJ, Lippi G. Mild hemophilia A. J Thromb Haemost 2010; 8(3): 421-32.
  2. Mansouritorghabeh H. Clinical and Laboratory Approaches to
    Hemophilia a. Iran J Med Sci 2015; 40(3): 194-205.
  3. Franchini M, Mannucci PM. Hemophilia A in the third millennium. Blood Rev 2013; 27(4): 179-84.
  4. Schulman S. Treatment of Hemophilia: Mild Hemophilia 2012; 41. p. 1-10. Available from: http://www1.wfh.org/publication/files/pdf-1192.pdf.
  5. Oldenburg J, Pavlova A. Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype. Hämostaseologie 2010; 30(4): 207-11.
  6. Bowyer AEVan Veen JJGoodeve ACKitchen SMakris M. Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A. Haematologica 2013; 98(12): 1980-7.
  7. Rodgers SE, Duncan EM, Barbulescu DM, Quinn DM, Lloyd JV. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and twostage factor VIII assay results. Br J Haematol 2007; 136(1): 138-45.
  8. Potgieter JJ, Damgaard M, Hillarp A. One-stage vs.
    chromogenic assays in haemophilia A. Eur J Haematol 2015; 94 Suppl 77: 38-44.
  9. Duncan EM, Rodgers SE, McRae SJ. Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII: C assays. Semin Thromb Hemost 2013; 39(3): 272-82.
  10. Trossaërt MBoisseau PQuemener ASigaud MFouassier MTernisien C, et al . Prevalence, biological phenotype and genotype in moderate/mild hemophilia A with discrepancy between one-stage and chromogenic factor VIII activity. J Thromb Haemost 2011; 9(3): 524-30.
  11. Cid ARCalabuig MCortina VCasaña PHaya SMoret A, et al. One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype. Haemophilia 2008; 14(5): 1049-54.
  12. Trossaert M, Lienhart A, Nougier C, Fretigny M, Sigaud M, Meunier S, et al. Diagnosis and management challenges in patients with mild hemophilia A and discrepant FVIII measurements. Haemophilia 2014; 20(4): 550-8.
 


 
 
 
 
Sci J Iran Blood Transfus Organ 2017; 13(4): 277-283
Original Article
 

 

The results of two methods of factor VIII:C in patients
 with hemophilia A
 
Vosough Shirayeh F.1, Ahmadinejad M.1, Toogeh Gh.2,3, Karimi K.3, Tabatabaei M.R.1,
Homayoun S.1
 
 
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3Thrombosis Hemostasis Research Center, Tehran University of Medical Sciences, Tehran, Iran
 
 
 
Abstract
Background and Objectives
FVIII activity (FVIII:C) is measured by clotting or chromogenic methods. The results of these methods may be different in some cases of hemophilia A that can cause misdiagnosis. The Aim of this study is to assess the results of two methods of F VIII:C assay in patients with hemophilia A.
 
Materials and Methods
In A descriptive survey research, FVIII:C level was measured using one-stage and chromogenic assays in 73 hemophilia A known patients. The data were analyzed by t-test and SPSS 22 statistical method. 
 
Results
From 73 patients in this study,  the range of FVIII:C assay by one-stage method  was 4% to 81% ( mean = 22.7 , SD = 14.8 ) and the range of FVIII:C assay by chromogenic method was 1% to 123 % ( mean=16.5 , SD = 21 ).
 
Conclusions 
For prevention of misdiagnosis, it is recommended to use two methods of FVIII:C assays for diagnosis of patients with hemophilia A.
 
Key words: Hemophilia A, Factor VIII, Prevalence
 
 
 
 
 
 
 
 
Received:  8 Mar 2016
Accepted: 8 Aug  2016
 
 

Correspondence: Ahmadinejad M., MD. Pathologist. Assistant Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 88212459; Fax: (+9821) 88601555
E-mail: minooam26@yahoo.com
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Vossough Shirayeh F, Ahmadinejad M, Toogeh G, karimi K, Tabatabaei M. The results of two methods of factor VIII:C in patients with hemophilia A. Sci J Iran Blood Transfus Organ 2016; 13 (4) :277-283
URL: http://bloodjournal.ir/article-1-1028-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13, Issue 4 (Winter 2016) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 39 queries by YEKTAWEB 4645